<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">17171990</PMID><DateCompleted><Year>2007</Year><Month>04</Month><Day>26</Day></DateCompleted><DateRevised><Year>2007</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1827-6806</ISSN><JournalIssue CitedMedium="Print"><Volume>7</Volume><Issue>10</Issue><PubDate><Year>2006</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Giornale italiano di cardiologia (2006)</Title><ISOAbbreviation>G Ital Cardiol (Rome)</ISOAbbreviation></Journal><ArticleTitle>[What does "p" mean at conclusion of a test of hypothesis in a randomized controlled clinical trial of superiority?].</ArticleTitle><Pagination><StartPage>684</StartPage><EndPage>686</EndPage><MedlinePgn>684-6</MedlinePgn></Pagination><Abstract><AbstractText>The aim of this statistical note, the sixth in the series, is to introduce the rationale of the test of hypothesis suitable for comparing the effect of two treatments in a randomized controlled clinical trial of superiority. The presentation takes advantage of the analogy with a criminal trial debate based upon circumstantial evidence in an Italian Court. The results of three randomized controlled clinical trials: ISIS-1, AIMS and RESTORE are introduced and proper ways for their interpretation are suggested.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Marubini</LastName><ForeName>Ettore</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Istituto di Statistica Medica e Biometria, Universit&#xe0; degli Studi, Milano. ettore.marubini@unimi.it</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallo</LastName><ForeName>Fabio</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Pizzamiglio</LastName><ForeName>Sara</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Verderio</LastName><ForeName>Paolo</ForeName><Initials>P</Initials></Author></AuthorList><Language>ita</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Note statistiche. Cosa significa "p"a conclusione di un test d'ipotesi in una sperimentazione clinica controllata di superiorit&#xe0;?</VernacularTitle></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>G Ital Cardiol (Rome)</MedlineTA><NlmUniqueID>101263411</NlmUniqueID><ISSNLinking>1827-6806</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009626" MajorTopicYN="Y">Terminology as Topic</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>12</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>4</Month><Day>27</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>12</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17171990</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>